Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Among 1,615 tirzepatide users who discontinued, nearly 28% regained lost weight after six months, while 36% maintained their weight loss and 36% continued losing weight
Regulatory Status RUO Other Names Insulin-like growth factor I, somatomedin C, Non-suppressible insulin-like activity I (NSILA-I), Insulin-Like Growth Factor IB, IBP1, Long R3 IGF1, Long Arg3 IGF1, Long R3 Insulin-like growth factor I Ave
Further drug development is needed to address these issues (Nakamura 2015
The fat loss data is real, and the metabolic benefits are significant
For broader context on research peptide sourcing in the US, see our research peptides overview guide
US$ 20.93
US$ 20.59
US$ 25.78
US$ 20.15
US$ 23.64
US$ 28.20
US$ 28.33
US$ 28.23
